ProQuad Dose Selection Study (V221-011)(COMPLETED)

NCT00986232 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1551
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC